Resources
Clear all
Show Filters
ZOLINZA is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma (CTCL) who have progressive, persistent or recurrent disease on or following two systemic therapies
The following side effects have been associated with use of zidovudine: Decrease in the number of white blood cells that help fight infection Decrease in the number of red blood cells that may cause weakness, dizziness, and fatigue Muscle aches, weakness, and wasting Headache Upset stomach…
RETROVIR is a nucleoside analogue reverse transcriptase inhibitor indicated for:* Treatment of Human Immunodeficiency Virus (HIV-1) infection in combination with other antiretroviral agents. (1.1) * Prevention of maternal-fetal HIV-1 transmission. (1.2)